Attana receives follow up contract research order from global pharma company
Attana has received a follow up contract research order from an global pharma company with headquarter in Europe. The contract is the results of the previous experiments and has an expanded range. The experiments are based on Attana’s patented cell-based biosensor and will included detailed interaction analysis between biopharmaceutical molecules and specific cells.Attana’s application specialists will perform experiments where the interactions between a specific target receptor in the cell membrane of three cell types and a number of different biopharmaceutical molecules with therapeutic